Cameron D. Thomas

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy”.

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta‐Blocker Therapy

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3351

N/A

1.4DataRank · unranked

67 citations

Cameron D. Thomas, Craig R. Lee, Rachel Huddart, José A. G. Agúndez, Jordan Baye +13 more

Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators

Clinical and Translational Science(2022)10.1111/cts.13376

N/A

0.650DataRank · unranked

22 citations

Emily J. Cicali, Kristin Wiisanen, Roger B. Fillingim, Hrishikesh Chakraborty, Rachel A. Myers +35 more

A hybrid implementation-effectiveness randomized trial of CYP2D6-guided postoperative pain management

Genetics in Medicine(2021)10.1038/s41436-020-01050-4

N/A

0.546DataRank · unranked

37 citations

Hari K. Parvataneni, Chancellor F. Gray, Justin T. Deen, Hernan A. Prieto, Luis Pulido +8 more

Evaluation of Potential Racial Disparities inCYP2C19‐Guided P2Y12Inhibitor Prescribing After Percutaneous Coronary Intervention

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2776

N/A

0DataRank · unranked

10 citations

Nita A. Limdi, Amber L. Beitelshees, James C. Lee, Julio D. Duarte, Francesco Franchi +17 more

Pharmacogenetics of P2Y 12 receptor inhibitors

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2023)10.1002/phar.2758

N/A

0DataRank · unranked

25 citations

Alexis K. Williams, Craig R. Lee, Larisa H. Cavallari, Cameron D. Thomas

Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.02.015

N/A

0DataRank · unranked

24 citations

Francesco Franchi, Joseph S. Rossi, Ellen C. Keeley, R. David Anderson, Amber L. Beitelshees +17 more

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2015

N/A

0DataRank · unranked

299 citations

Cameron D. Thomas, Julia M. Barbarino, Zeruesenay Desta, Sara L. Van Driest, Nihal El Rouby +15 more

Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel‐Treated Participants

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.70045

N/A

0DataRank · unranked

0 citations

Cameron D. Thomas, Claudio Laudani, Salvatore Giordano, Francesco Franchi, Kayla R. Tunehag +13 more

Pharmacogenetic factors affecting β-blocker metabolism and response

Expert Opinion on Drug Metabolism & Toxicology(2020)10.1080/17425255.2020.1803279

N/A

0DataRank · unranked

46 citations

Julie A. Johnson, Cameron D. Thomas

How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2354

N/A

0DataRank · unranked

90 citations

Amanda L. Elchynski, Kelsey J. Cook, John T. Houder, Cameron D. Thomas, D. Max Smith +5 more